基于阿昔洛韦相关医疗损害责任纠纷的药学服务探讨

    Research on the Pharmaceutical Care Based on Acyclovir Related Medical Damage Liability Disputes

    • 摘要: 目的 从医疗损害责任纠纷案件中学习常见的药学相关问题,探讨合理用药。方法 以阿昔洛韦相关医疗损害责任纠纷为例,选取中国裁判文书网以"医疗损害责任纠纷"为案由的6例"阿昔洛韦"药学相关医疗损害责任纠纷案件进行描述性分析。结果 6个案例均在合理用药方面、谨慎注意义务方面和知情同意告知方面存在不足,对药物不良反应的预见、告知、回避和处理方面也存在欠缺。结论 药师应在药物治疗中协助医师尽到谨慎注意义务和知情同意告知义务,努力降低药学相关医疗损害责任纠纷。

       

      Abstract: OBJECTIVE To learn from the cases of medical damage liability disputes, and promote rational drug use. METHODS Acyclovir was selected as model drug, and 6 cases in web of China judgements online were chosen using the "medical damage liability disputes" with drugs limited to "acyclovir", and the descriptive analysis on 6 cases was done. RESULTS The 6 cases were deficient in rational drug use, duty of cautious attention and duty of informed consent. There were also deficiencies in the prediction, information, avoidance and treatment of adverse drug reactions. CONCLUSION Pharmacists should assist doctors to do a duty of cautious attention and informed consent to reduce medical damage liability disputes related to pharmacy.

       

    /

    返回文章
    返回